---
title: "coral"
slug: "coral"
date: "2024-05-09"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ªï¼š[[post-transplant_maintenance_therapy]]

# coral

[Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study - PubMed](https://pubmed.ncbi.nlm.nih.gov/26367239/)

1. - Design: Phase - III
   - Multicenter trial
   - Not reported if randomized or open-label/blind
2. - Number of patients: 203
3. - Patients characteristics: Patients with relapsed and refractory diffuse large B-cell lymphoma who could not proceed to autologous stem cell transplantation
4. - Agent:
   - Intervention: Salvage chemotherapy
   - Control: Not reported
   - Dose: Not reported
5. - Treatment line: Third-line treatment
6. - Trial Acronym (if provided) or NCTId Number: CORAL trial (Collaborative Trial in Relapsed Aggressive Lymphoma)
7. - Comparison of outcomes:

| Outcome | Third-line chemotherapy (%)                   | Transplanted (%)                                                   |
| ------- | --------------------------------------------- | ------------------------------------------------------------------ |
| PFS)    | Not reported                                  | Not reported                                                       |
| OS)     | 4.4 months                                    | 1-year OS of 41.6% for transplanted vs. 16.3% for not transplanted |
| RR)     | 39% overall response rate, 27% CR/CRu, 12% PR | Not reported                                                       |
